Guru Ownership Trend
Guru Analysis for Sangamo Therapeutics, Inc. (SGMO)
Sangamo Therapeutics, Inc. (SGMO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $450,808.14.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.16 M net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 54.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Sangamo Therapeutics, Inc. (SGMO)
Major holders include Renaissance Technologies (RenTech) ($947,273). According to the latest reported data, 1 tracked investment managers collectively hold approximately 3.84 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.16 M, with 0 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited SGMO. The total reported sell value was $1.16 M.
No tracked managers opened new positions or increased their holdings in SGMO during the most recent reporting period.